These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15388618)

  • 1. Taking account of future technology in cost effectiveness analysis.
    Salomon JA; Weinstein MC; Goldie SJ
    BMJ; 2004 Sep; 329(7468):733-6. PubMed ID: 15388618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine hepatitis C virus screening in pregnancy: a cost-effectiveness analysis.
    Plunkett BA; Grobman WA
    Am J Obstet Gynecol; 2005 Apr; 192(4):1153-61. PubMed ID: 15846195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac transplantation: the second round.
    Lancet; 1980 Mar; 1(8170):687-8. PubMed ID: 6103094
    [No Abstract]   [Full Text] [Related]  

  • 4. Much cheaper, almost as good: decrementally cost-effective medical innovation.
    Nelson AL; Cohen JT; Greenberg D; Kent DM
    Ann Intern Med; 2009 Nov; 151(9):662-7. PubMed ID: 19884627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the effectiveness of new medical technology].
    Kuznetsov VS; Guziukina TV; Orlova ER
    Sov Zdravookhr; 1990; (12):8-11. PubMed ID: 2128135
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost effectiveness of interferon in chronic active hepatitis C.
    Turnbull C; Sugano D
    Med J Aust; 1994 Jul; 161(2):169; author reply 170. PubMed ID: 8028544
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
    Lin OS; Keeffe EB; Sanders GD; Owens DK
    Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
    Chapko MK; Yee HS; Monto A; Dominitz JA
    Vaccine; 2010 Feb; 28(7):1726-31. PubMed ID: 20044051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medico-economic evaluation: aims, methodology, limits].
    Daures JP; Delande G
    Gastroenterol Clin Biol; 2000 Nov; 24(11):1029-31. PubMed ID: 11139670
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of captopril therapy after myocardial infarction.
    Tsevat J; Duke D; Goldman L; Pfeffer MA; Lamas GA; Soukup JR; Kuntz KM; Lee TH
    J Am Coll Cardiol; 1995 Oct; 26(4):914-9. PubMed ID: 7560617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
    Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
    Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology: redesigning the medical system.
    Kaiser LR
    Med Group Manage J; 1992; 39(6):20-4. PubMed ID: 10122766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of chronic hepatitis C: doubts about a cost-effectiveness analysis].
    Bergmann JF
    Gastroenterol Clin Biol; 1997; 21(4):336-8. PubMed ID: 9208001
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer; 2008 Mar; 112(5):1058-65. PubMed ID: 18186497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the cost-effectiveness of hepatitis C treatment for injecting drug users on methadone maintenance in New Zealand?
    Sheerin IG; Green FT; Sellman JD
    Drug Alcohol Rev; 2004 Sep; 23(3):261-72. PubMed ID: 15370005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cost-effectiveness analysis of the treatment of chronic hepatitis C].
    Joliot E; Vanlemmens C; Kerleau M; Le Gales C; Woronoff-Lemsi MC; Flori YA; Seror V; Hrusovsky S; Monnet E; Bresson-Hadni S; Miguet JP
    Gastroenterol Clin Biol; 1996; 20(11):958-67. PubMed ID: 9119185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of interferon in chronic active hepatitis C.
    Sallie R
    Med J Aust; 1994 Jul; 161(2):169-70. PubMed ID: 8080533
    [No Abstract]   [Full Text] [Related]  

  • 18. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C.
    Shiell A; Briggs A; Farrell GC
    Med J Aust; 1994 Mar; 160(5):268-72. PubMed ID: 8107627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal.
    Dusheiko GM; Roberts JA
    Hepatology; 1995 Dec; 22(6):1863-73. PubMed ID: 7489999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of testing and treatment for asymptomatic diseases.
    Kirkizlar E; Faissol DM; Griffin PM; Swann JL
    Math Biosci; 2010 Jul; 226(1):28-37. PubMed ID: 20361985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.